|
2025
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Process for the crystallization of estetrol monohydrate. The present disclosure relates to a crys... |
|
2024
|
Invention
|
Thiadiazine derivatives.
The invention relates to thiadiazine derivatives, or pharmaceutically a... |
|
|
Invention
|
11c radiolabeled mchr1 pet ligands. The present invention provides radiolabeled 2, 3, 4, 5 -tetra... |
|
|
Invention
|
Dopamine d3/d2 receptor modulating compounds.
The present disclosure provides for compounds of F... |
|
|
Invention
|
Method for the manufacture of biopharmaceuticals.
Provided is a thermo-regulated process for the... |
|
|
Invention
|
Substituted piperazines as dopamine d3/d2 receptor modulators. The present disclosure provides fo... |
|
|
Invention
|
Dopamine d3/d2 receptor modulating compounds. The present disclosure provides for compounds of Fo... |
|
2023
|
Invention
|
Orally disintegrating pharmaceutical tablet containing cariprazine. An orally disintegrating phar... |
|
|
Invention
|
Crystalline forms of 4-[(5-chloropyridin-2-yl)methoxy]-1-[3-(propan-2-yl)-1h,2h,3h,4h,5h-[1,4]dia... |
|
|
Invention
|
Mchr1 antagonists for the treatment of prader-willi syndrome. The present invention relates to us... |
|
|
Invention
|
Method for the manufacture of biopharmaceuticals. Provided is a thermo-regulated process for the ... |
|
2022
|
Invention
|
Carbamoyl cyclohexane derivatives for treating autism spectrum disorder.
The present invention r... |
|
|
Invention
|
Crystalline form of an ethanol solvate of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-... |
|
|
Invention
|
Bicyclic amine derivatives as gabaa alpha5 receptor modulators.
The present invention provides c... |
|
|
Invention
|
Bicyclic amine derivatives as gabaa α5 receptor modulators. AAA α5 receptor, process for the prep... |
|
|
Invention
|
Process to produce (1r,4r)-4-substituted cyclohexane-1-amines.
The invention relates to a proces... |
|
|
Invention
|
R)-4-substituted cyclohexane-1-amines. rrtranstrans1-6transtranstranstranstranstrans-4-((1,3-diox... |
|
|
Invention
|
Controlled release injectable cariprazine formulation. The present invention relates to controlle... |
|
|
Invention
|
Method for increasing the galactose content of recombinant proteins.
The present invention relat... |
|
|
Invention
|
Process for consecutive continuous-flow reductions in the synthesis of medicinally relevant piper... |
|
|
Invention
|
Mutated recombinant ace2-fc fusion proteins for the treatment of covid-19 infections. The inventi... |
|
2021
|
Invention
|
Methods for the purification of refolded fc-peptide fusion protein.
The present invention relate... |
|
|
Invention
|
Methods for the purification of refolded fc-peptide fusion protein. The present invention relates... |
|
|
Invention
|
Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder.... |
|
|
Invention
|
Remdesivir intermediates. The present invention relates to a process for the preparation of a com... |
|
|
Invention
|
Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives.
The inv... |
|
|
Invention
|
Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives. The inve... |
|
|
Invention
|
Pharmaceutical anti-tnf-alpha antibody formulation.
Provided are improved storage-stable liquid ... |
|
|
Invention
|
Naphthyridine and pyrido[3,4-c]pyridazine derivatives as gabaa alpha 5 receptor modulators.
The ... |
|
|
Invention
|
1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators.
The present i... |
|
|
Invention
|
H-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators. AAA α5 receptor, process fo... |
|
|
Invention
|
A α5 receptor modulators. AAA α5 receptor, process for the preparation and intermediates of the p... |
|
2020
|
Invention
|
Method for identifying drug candidate compounds. The present invention relates to a method for te... |
|
|
Invention
|
Industrial process for the preparation of high purity estetrol. The invention relates to the prep... |
|
|
Invention
|
Selective histamine h3 receptor antagonists for treating autism spectrum disorder.
The present i... |
|
|
Invention
|
Selective histamine h3 antagonist acid addition salts and process for the preparation thereof.
T... |
|
|
Invention
|
Selective histamine h3 antagonist acid addition salts and process for the preparation thereof. 33... |
|
|
Invention
|
Selective histamine h3 receptor antagonists for treating autism spectrum disorder. The present in... |
|
|
Invention
|
Improvement of affinity chromatography of immunoglobulins by using pre-capture flocculation.
The... |
|
2019
|
Invention
|
Method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell cul... |
|
|
Invention
|
Aqueous pharmaceutical formulations.
Provided are an aqueous pharmaceutical formulation comprisi... |
|
|
Invention
|
Bicyclic derivatives as gabaa a5 receptor modulators. A α5 receptor, process for the preparation ... |
|
|
Invention
|
Spirochromane derivatives.
The invention relates to spirochromane derivatives, or pharmaceutical... |
|
|
Invention
|
Thiadiazine derivatives. The invention relates to thiadiazine derivatives, or pharmaceutically ac... |
|
|
Invention
|
Pharmaceutical formulations containing dopamine receptor ligands. The present invention relates t... |
|
2018
|
Invention
|
Triazolobenzazepines as vasopressin v1a receptor antagonists. The present invention relates to 5,... |
|
2017
|
Invention
|
Industrial process for the synthesis of nomegestrol-acetate. The invention relates to the last st... |
|
|
Invention
|
Industrial process for the preparation of cariprazine. In the process of the present invention, c... |
